Trials / Sponsors / Shanghai Biomabs Pharmaceutical Co., Ltd.
Shanghai Biomabs Pharmaceutical Co., Ltd.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Phase I Study to Compare CMAB818 Injection and Lucentis® in Patients With Wet AMD Wet Age-related Macular Degeneration | Phase 1 | 2021-06-03 |
| Completed | Clinical Efficacy and Safety Comparative Study Between CMAB807 Injection and Prolia® . Postmenopausal Osteoporosis | Phase 3 | 2021-03-31 |
| Completed | Phase 1 Study to Compare CMAB807 Injection to Prolia® in Healthy Volunteers Postmenopausal Osteoporosis | Phase 1 | 2019-07-01 |
| Completed | Anti-IgE Monoclonal Antibody Treatment in Patients With Allergic Asthma. Asthma, Allergic | Phase 3 | 2018-05-09 |
| Completed | CMAB008 With MTX Therapy in Adult Patients With Moderately to Severely Active Rheumatoid Arthritis Rheumatoid Arthritis | Phase 3 | 2018-03-30 |